Rapid tumor development with a modified MCF-7 xenograft model

被引:0
|
作者
Hale, LV
Layman, NK
Wilson, P
Short, LL
Magee, DE
Wightman, SR
FuchsYoung, R
机构
[1] ELI LILLY & CO,LILLY CORP CTR,LILLY RES LABS,DEPT ENDOCRINOL,INDIANAPOLIS,IN 46285
[2] ELI LILLY & CO,LILLY CORP CTR,LILLY RES LABS,DEPT LAB ANIM SERV,INDIANAPOLIS,IN 46285
来源
LABORATORY ANIMAL SCIENCE | 1997年 / 47卷 / 01期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:82 / 85
页数:4
相关论文
共 50 条
  • [21] FORMATION OF MULTICELLULAR TUMOR SPHEROIDS BY MCF-7 AND SENSITIVITY TO ANTICANCER THERAPY
    Demianenko, D.
    Perepelytsina, O.
    Gergeliuk, T.
    Sydorenko, M.
    BREAST, 2013, 22 : S85 - S85
  • [22] Trastuzumab and Liposomal Doxorubicin in the Treatment of MCF-7 Xenograft Tumor-Bearing Mice: Combination Does Not Affect Drug Serum Levels
    Dawn N. Waterhouse
    Tetyana Denyssevych
    Norma Hudon
    Stephen Chia
    Karen A. Gelmon
    Marcel B. Bally
    Pharmaceutical Research, 2005, 22 : 915 - 922
  • [23] Pkc and p21: Tumor promoters in MCF-7 cells?
    Valacchi, G
    Fortino, V
    Maioli, M
    Torricelli, C
    Capurro, E
    FASEB JOURNAL, 2005, 19 (05): : A1197 - A1197
  • [24] MCF-7 and MCF-7/ADR cells respond differently to changes in glucose concentrations.
    Sridhar, R
    Yamamoto, M
    Patel, NA
    Cooper, DR
    FASEB JOURNAL, 1999, 13 (05): : A920 - A920
  • [25] The molecular mechanism of xanthohumol-induced apoptosis in MCF-7 and MCF-7/ADR cells
    Kang, Youra
    Park, Min-A
    Kang, Keon-Wook
    Kim, Jung-Ae
    FASEB JOURNAL, 2010, 24
  • [26] Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells
    Wen, Chunjie
    Wu, Lanxiang
    Fu, Lijuan
    Zhang, Xue
    Zhou, Honghao
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 2250 - 2256
  • [27] Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin
    Plonka-Czerw, Justyna
    Zyrek, Luiza
    Latocha, Malgorzata
    MOLECULES, 2024, 29 (15):
  • [28] Comparison of the selective estrogen receptor. modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft model
    Detre, S
    Riddler, S
    Salter, J
    A'Hern, R
    Dowsett, M
    Johnston, SRD
    CANCER RESEARCH, 2003, 63 (19) : 6516 - 6522
  • [29] A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells
    Song, Qin
    Chuan, Xingxing
    Chen, Binlong
    He, Bing
    Zhang, Hua
    Dai, Wenbing
    Wang, Xueqing
    Zhang, Qiang
    DRUG DELIVERY, 2016, 23 (05) : 1734 - 1746
  • [30] Senescence evasion by MCF-7 human breast tumor-initiating cells
    Feridoun Karimi-Busheri
    Aghdass Rasouli-Nia
    John R Mackey
    Michael Weinfeld
    Breast Cancer Research, 12